Related Experiment Video
Updated: Apr 13, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
11.9K
Amphiphilic Polymeric Micelle Spherical Nucleic Acids (SNAs) as Drug Delivery Vehicles
John P Cavaliere1,2, Connor M Forsyth3,2, Allen X Guo4,2
1Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States.
Bioconjugate Chemistry
|December 19, 2025
Summary
Researchers developed novel amphiphilic polymeric micelle-spherical nucleic acids (APM-SNAs) for enhanced hydrophobic drug delivery. These APM-SNAs show improved cellular uptake, drug encapsulation, and therapeutic efficacy by tuning core hydrophobicity and oligonucleotide density.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Spherical nucleic acids (SNAs) offer unique properties for biomedical applications.
- Amphiphilic polymeric micelles (APMs) are promising nanocarriers for hydrophobic drugs.
- Developing efficient delivery systems for hydrophobic therapeutics remains a challenge.
Purpose of the Study:
- To synthesize and characterize a new class of APM-derived SNAs (APM-SNAs) for hydrophobic drug delivery.
- To investigate the impact of APM-SNA structure, including core hydrophobicity and oligonucleotide density, on cellular uptake, drug loading, and therapeutic efficacy.
- To evaluate the performance of APM-SNAs in delivering a specific STAT3 inhibitor, WP1066.
Main Methods:
- Synthesis of amphiphilic copolymers with varying hydrophobic blocks (e.g., benzyl methacrylate, n-butyl methacrylate) and a hydrophilic polyethylene glycol block.
- Conjugation of alkyne-modified oligonucleotides to azide-terminated polymer cores via click chemistry to form APM-SNAs.
- Characterization of APM-SNAs, including cellular uptake studies, immune activation assays, drug encapsulation efficiency, and in vitro drug release kinetics.
- Assessment of therapeutic efficacy using a STAT3 inhibitor (WP1066) in Caki-1 cells.
Main Results:
- Cellular uptake of APM-SNAs increased up to 10-fold with higher oligonucleotide densities.
- APM-SNAs with increased core hydrophobicity (benzyl methacrylate) showed enhanced cellular uptake and improved WP1066 encapsulation (67% vs 41%) and release profiles (half-life 27.8 vs 7.4 h).
- Oligonucleotide sequence influenced cellular uptake, with T20-SNAs showing ~40% greater uptake than CpG and G-quadruplex sequences.
- WP1066 delivered via T20 benzyl APM-SNAs demonstrated a 40% improvement in potency, reducing EC50 from 6.18 to 3.54 μM.
Conclusions:
- APM-SNAs represent a versatile platform for hydrophobic drug delivery, with tunable structural properties.
- Increasing the hydrophobicity of the APM-SNA core and optimizing drug-core interactions significantly enhance drug encapsulation, prolong release, and improve therapeutic outcomes.
- These findings highlight the potential of APM-SNAs for developing more effective nanomedicines for challenging hydrophobic drugs.
Related Concept Videos
01:30Micelles
269
Micelle formation is an intricate process that hinges on the properties of amphiphilic or amphipathic molecules and the conditions of the system in which they are found. Amphiphilic molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts, play a critical role in this process.In aqueous environments, these molecules arrange themselves such that their hydrophilic heads are turned towards the water phase, while their hydrophobic tails are oriented away...
269
01:24Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127